Marshall Wace’s Harvard Bioscience HBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $61K | Buy |
+138,700
| New | +$61K | ﹤0.01% | 2436 |
|
|
2023
Q3 | – | Sell |
-54,645
| Closed | -$300K | – | 2049 |
|
|
2023
Q2 | $300K | Buy |
+54,645
| New | +$300K | ﹤0.01% | 1723 |
|
|
2022
Q4 | – | Sell |
-76,923
| Closed | -$196K | – | 2525 |
|
|
2022
Q3 | $196K | Buy |
76,923
+23,558
| +44% | +$60K | ﹤0.01% | 2348 |
|
|
2022
Q2 | $192K | Buy |
+53,365
| New | +$192K | ﹤0.01% | 2468 |
|
|
2021
Q3 | – | Sell |
-29,280
| Closed | -$244K | – | 2567 |
|
|
2021
Q2 | $244K | Buy |
29,280
+2,676
| +10% | +$22.3K | ﹤0.01% | 1888 |
|
|
2021
Q1 | $145K | Buy |
+26,604
| New | +$145K | ﹤0.01% | 1985 |
|
|
2020
Q1 | – | Sell |
-142,138
| Closed | -$434K | – | 1781 |
|
|
2019
Q4 | $434K | Sell |
142,138
-183,310
| -56% | -$560K | ﹤0.01% | 1160 |
|
|
2019
Q3 | $1M | Sell |
325,448
-87,400
| -21% | -$269K | 0.01% | 907 |
|
|
2019
Q2 | $826K | Buy |
412,848
+326,305
| +377% | +$653K | 0.01% | 951 |
|
|
2019
Q1 | $373K | Buy |
86,543
+74,089
| +595% | +$319K | ﹤0.01% | 1207 |
|
|
2018
Q4 | $40K | Sell |
12,454
-11,046
| -47% | -$35.5K | ﹤0.01% | 1466 |
|
|
2018
Q3 | $123K | Buy |
+23,500
| New | +$123K | ﹤0.01% | 1093 |
|